News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233 Results
Type
Article (36)
Company Profile (1)
Press Release (196)
Section
Business (113)
Deals (16)
Drug Development (34)
Job Trends (23)
News (138)
Policy (2)
Tag
Alliances (17)
Best Places to Work (23)
Breast cancer (3)
Cancer (5)
Clinical research (21)
Collaboration (1)
COVID-19 (2)
Cystic fibrosis (1)
Earnings (35)
Events (55)
Featured Employer (1)
Government (1)
Healthcare (5)
Infectious disease (2)
IPO (12)
Job creations (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (3)
NextGen Class of 2024 (4)
People (54)
Pharmaceutical (1)
Phase I (16)
Phase II (12)
Phase III (3)
Preclinical (6)
Prostate cancer (3)
Rare diseases (1)
Regulatory (1)
Startups (10)
United States (12)
Venture capitalists (1)
Date
Last 30 days (3)
Last 365 days (43)
2024 (38)
2023 (35)
2022 (34)
2021 (33)
2020 (31)
2019 (21)
2018 (12)
2017 (9)
2016 (8)
2015 (7)
2014 (4)
2013 (1)
Location
Asia (1)
Canada (1)
Connecticut (7)
Europe (12)
Massachusetts (2)
New York (1)
North Carolina (1)
Pennsylvania (1)
233 Results for "arvinas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arvinas to Participate in Upcoming November 2024 Investor Conferences
November 5, 2024
·
1 min read
Pharm Country
Arvinas to Participate in Upcoming Investor Conferences
Arvinas, Inc. today announced that management will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on Thursday, June 6 in New York City.
June 3, 2024
·
2 min read
Business
Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
Arvinas, Inc. announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer reporting to Chairperson, Chief Executive Officer, and President, John Houston, Ph.D.
June 24, 2024
·
6 min read
Press Releases
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 30, 2024
·
15 min read
Business
Arvinas to Participate in Upcoming Investor Conferences
August 29, 2024
·
1 min read
Pharm Country
Arvinas to Present at Upcoming May 2024 Investor Conferences
Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that management will participate in two upcoming investor conferences:
May 2, 2024
·
1 min read
Business
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
Arvinas, Inc. announced the appointment of Randy Teel, Ph.D., to the newly created role of Chief Business Officer.
April 24, 2024
·
4 min read
Business
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 7, 2024
·
16 min read
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space
As its lead oral targeted protein degrader moves through Phase III in partnership with Pfizer, Arvinas signs a licensing deal handing over all rights and responsibilities to Novartis.
April 17, 2024
·
4 min read
·
Neil Versel
Press Releases
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024
October 21, 2024
·
1 min read
1 of 24
Next
